WMT

115.03

+1.14%↑

139.62

+1.01%↑

70.08

-0.19%↓

150.36

+1.31%↑

PEP

144.62

-0.64%↓

WMT

115.03

+1.14%↑

139.62

+1.01%↑

70.08

-0.19%↓

150.36

+1.31%↑

PEP

144.62

-0.64%↓

WMT

115.03

+1.14%↑

139.62

+1.01%↑

70.08

-0.19%↓

150.36

+1.31%↑

PEP

144.62

-0.64%↓

WMT

115.03

+1.14%↑

139.62

+1.01%↑

70.08

-0.19%↓

150.36

+1.31%↑

PEP

144.62

-0.64%↓

WMT

115.03

+1.14%↑

139.62

+1.01%↑

70.08

-0.19%↓

150.36

+1.31%↑

PEP

144.62

-0.64%↓

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

7.57 0.8

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.18

Max

7.66

Schlüsselkennzahlen
By Trading Economics
Einkommen	-7.9M -10M
Verkäufe	-5.3M 31M
Gewinnspanne	-32.116
Angestellte	406

Dividenden
By Dow Jones
Nächstes Ergebnis	2. Jan. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	7.5M 249M
Vorheriger Eröffnungskurs	6.77
Vorheriger Schlusskurs	7.57

Nachrichtenstimmung

By Acuity

20%

80%

18 / 148 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Dez. 2025, 22:13 UTC

Ergebnisse

GE Vernova Raises Outlook, Doubles Dividend on Energy Market Momentum

9. Dez. 2025, 21:40 UTC

Ergebnisse

GameStop Sales Fall as Collectibles Remain Only Bright Spot

9. Dez. 2025, 18:51 UTC

Akquisitionen, Fusionen, Übernahmen

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9. Dez. 2025, 16:57 UTC

Wichtige Markttreiber

Clear Secure Rises on Medicare Identity Verification Contract

9. Dez. 2025, 23:46 UTC

Market Talk

Nikkei May Trade Rangebound Ahead of Fed Rate Decision -- Market Talk

9. Dez. 2025, 23:46 UTC

Akquisitionen, Fusionen, Übernahmen

Legend Holdings Stake in Lenovo Now at 32.34%

9. Dez. 2025, 23:45 UTC

Akquisitionen, Fusionen, Übernahmen

Legend Holdings: Remains Optimistic About Lenovo's Future Development Potential

9. Dez. 2025, 23:44 UTC

Akquisitionen, Fusionen, Übernahmen

Legend Holdings: Purchased Lenovo Shares at Average Price of HK$9.7653/Share

9. Dez. 2025, 23:43 UTC

Akquisitionen, Fusionen, Übernahmen

Legend Holdings: Acquired Lenovo Shares for Total Cash Consideration of HK$1.12B

9. Dez. 2025, 23:43 UTC

Akquisitionen, Fusionen, Übernahmen

Legend Holdings: Acquired 115.17M Lenovo Shares From Open Market Between Nov. 21 and Dec. 9

9. Dez. 2025, 23:35 UTC

Market Talk

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

9. Dez. 2025, 22:42 UTC

Ergebnisse

PepsiCo Wants to Boost Sales, Cut Costs. The Street Is Doubtful. -- Barrons.com

9. Dez. 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Dez. 2025, 21:48 UTC

Market Talk

Hiring Confidence Slips in Canada Entering 2026 -- Market Talk

9. Dez. 2025, 21:36 UTC

Ergebnisse

Casey's General Stores: Fiscal 2026 EBITDA Is Expected to Increase 15% to 17% >CASY

9. Dez. 2025, 21:36 UTC

Ergebnisse

Casey's General Stores: Total Inside Gross Profit Increased 13.5% to $703.4M Compared to Prior Yr >CASY

9. Dez. 2025, 21:36 UTC

Ergebnisse

Casey's General Stores: Now Expects Inside Same-Store Sales to Increase 3% to 4% and an Inside Margin of 41% to 42% >CASY

9. Dez. 2025, 21:36 UTC

Ergebnisse

Casey's General Stores: Same-Store Fuel Gallons Up 0.8% Compared to Prior Yr With Fuel Margin of 41.6 Cents per Gallon, Total Fuel Gross Profit Increased 20.9% to $377.4M Compared to Prior Yr >CASY

9. Dez. 2025, 21:36 UTC

Ergebnisse

Casey's General Stores: Inside Same-Store Sales Increased 3.3% Compared to Prior Yr, and 7.5% on 2-Yr Stack Basis, With an Inside Margin of 42.4% >CASY

9. Dez. 2025, 20:28 UTC

Market Talk

Oil Futures Decline for Second Straight Session -- Market Talk

9. Dez. 2025, 20:27 UTC

Akquisitionen, Fusionen, Übernahmen

Teck Resources: Merger of Equals With Anglo Amer Plc Approved by Both Classes of Teck Hldrs

9. Dez. 2025, 20:27 UTC

Akquisitionen, Fusionen, Übernahmen

Teck Reports Voting Results From Special Meeting of Hldrs

9. Dez. 2025, 20:26 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Moody's: Paramount's Warner Bid Makes Strategic Sense, With Risk -- Market Talk

9. Dez. 2025, 20:21 UTC

Market Talk

U.S. Natural Gas Extends Pullback on Shifting Weather Outlook -- Market Talk

9. Dez. 2025, 19:52 UTC

Ergebnisse

Correction to 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com on Dec. 8

9. Dez. 2025, 19:17 UTC

Ergebnisse

Update: 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com

9. Dez. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Dez. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9. Dez. 2025, 17:11 UTC

Ergebnisse

Nvidia Has Permission to Sell H200 Chips to China. Why It Might Not Matter Much for the Stock. -- Barrons.com

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Rating-Konsens

By TipRanks

Buy

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

18 / 148 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.